Cost savings in biomolecule purification together with high stability — The Eshmuno™ product line has been expanded to include a fast, efficient chromatography resin featuring the well-known tentacle technology

Darmstadt — Merck KGaA will present its new biochromatography resin Eshmuno™ Q at the 10th Biological Production Forum 2010, which is taking place from June 21 to 23 in Frankfurt. Merck is using the industry event of the biopharmaceutical industry in order to showcase its expertise in purification and formulation for biomolecule production.

High stability and improved flow rate of Eshmuno™ Q

The ion exchange resins of the Eshmuno™ product line have been specifically designed for highly efficient purification in biopharmaceutical processes. Last year saw the successful launch of the cation exchanger Eshmuno™ S. The new anion exchanger Eshmuno™ Q enables high flow rates together with high binding capacity. With the aid of active tentacle technology, proteins, antibodies and other biomolecules can be bound even more effectively. Thus, Eshmuno™ Q is suitable not only for the purification of recombinant products, but also for use in the biotechnological production of blood plasma, thus supplementing Merck’s portfolio for biopharmaceutical applications.